Abstract
We report a heart transplant recipient with Rhodococcus equi and Cryptococcus neoformans infection. Despite an initially relapsing course and the acquisition of resistance in vivo, the patient responded to 5 months of linezolid and 6 months of fluconazole. This is the 1st R. equi infection to be cured with linezolid in a heart transplant recipient.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetamides / therapeutic use*
-
Actinomycetales Infections / drug therapy*
-
Actinomycetales Infections / microbiology*
-
Anti-Bacterial Agents / therapeutic use*
-
Cryptococcosis / drug therapy
-
Cryptococcosis / microbiology
-
Cryptococcus neoformans / drug effects
-
Cryptococcus neoformans / isolation & purification
-
Drug Resistance, Bacterial
-
Fluconazole / therapeutic use
-
Heart Diseases / complications
-
Humans
-
Linezolid
-
Male
-
Middle Aged
-
Oxazolidinones / therapeutic use*
-
Recurrence
-
Rhodococcus equi / drug effects
-
Rhodococcus equi / isolation & purification*
-
Transplantation*
-
Treatment Outcome
Substances
-
Acetamides
-
Anti-Bacterial Agents
-
Oxazolidinones
-
Fluconazole
-
Linezolid